Therapy Cells, Inc. (OTC:TCEL)
Industry: Basic Materials

OFF LIST - 501 consecutive market days: OFF LIST as of 01/03/2014 Through 11/14/2016

Therapy Cells, Inc. develops and commercializes a technology for tendon repair for the human market. Its technology is used for tissue transplantation to aid in the repair and regeneration of damaged, diseased, torn, or ruptured musculoskeletal cells and organs in the human, as well as to grow pancreatic cells, for treatment of diabetes, cardiac cells for the treatment of heart disease, and other cell types from various other tissues. The company was formerly known as Diamond Information Institute, Inc. and changed its name to Therapy Cells, Inc. in May 2011. Therapy Cells, Inc. was founded in 1988 and is based in Las Vegas, Nevada.

Current Quote*
Last: $0.000
Change: 0.000
Book: $Unk
Volume: 9,144,442

As Of: 11/20 16:04 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol TCEL

  • No BuyIns.Net Alerts Available for TCEL

Graphs for TCEL

3 Month Graph

6 Month Graph

1 Year Graph